Top Markets
Coin of the day
Scilex Holding Company Scilex Holding Company

Scilex Holding Company

SCLX
शेयरों में रैंक #25626
Scilex Holding Company is a biopharmaceutical enterprise that specializes in... Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
शेयर मूल्य
$5.61
अंतिम समन्वयन: 2026-08-20
मार्केट कैप
$47.65M
बदलाव (1 दिन)
-0.68%
बदलाव (1 वर्ष)
-67.26%
देश
US
व्यापार Scilex Holding Company (SCLX)

श्रेणी

Scilex Holding Company (SCLX) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $6.52 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $346.22 (2021-03-01 को)
Scilex Holding Company के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -26.12%
2025 -11.79%
2024 -61.32%
2023 -63.10%
2022 -63.74%
2021 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$1.25K 75.69%
US
$268.08 49.82%
US
$262.00 25.06%
US
$489.01 44.10%
CH
$149.16 73.28%
US